Skip to main content
. Author manuscript; available in PMC: 2013 Mar 12.
Published in final edited form as: Hypertens Res. 2012 Nov 15;36(3):262–269. doi: 10.1038/hr.2012.184

Table 2.

Medications used during the study

Medication Olmesartan, n=22 Non-ARB, n=23 P-value
Calcium channel blockers (%) 77 96 0.096
Diuretics (%) 36 57 0.175
ACEI (%) 14 57 0.003
Statins (%) 23 35 0.372
Oral hypoglycemic agents (%) 32 17 0.187
Insulin (%) 18 4 0.260

Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II type 1 receptor blocker.